U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• Empowering Coffeehouse Leaders: Starbucks expands Assistant Manager Role across the U.S. - Starbucks Coffee
• Why do some people have loving parents and some do not?
• What should I be looking for when trying out running shoes? Local store lets me try the shoe and jog up and down the block, but they mostly feel the same to me. Is there some feeling or anything else specific I should be looking for?
• Dazzling Royal Diamonds and Pearls to Celebrate Trooping the Colour in London - The Court Jeweller
• What are your thoughts on a future where code is represented as a structured model, rather than text? Do you think that AI-powered coding assistants benefit from that?
• Have you ever witnessed political correctness harm someone?
• Supernovas may have triggered life-threatening changes in ancient Earth's climate. Scientists say it could happen again - Space
• Why do guys have better skin than women even though women use more product?
• Mario Kart World: All Costume Unlocks & Complete Outfit List - Nintendo Life
• Ever-changing universe revealed in first imagery from NSF-DOE Vera C. Rubin Observatory - National Science Foundation (.gov)
• What is the most peculiar thing about the human brain?
• The Undervalued Medical Power of Muscle - Medscape
• Which Bibles can one read and be confident they are reading the inerrant word of God?
• Exercise improves colon cancer survival, high-quality trial finds - Ars Technica